Company intelligence / Profile preview

프로메디스

Seoul, Seoul, South Koreakr.linkedin.com ↗

Ownership: Private
Employees: ~46
Development stage: Other

Overview

프로메디스 is an established Korean CRO specializing in comprehensive clinical trial services for pharmaceuticals and medical devices. The company has managed over 280 clinical trial projects since its founding, including early-phase to post-marketing studies. It is particularly strong in the field of medical device trials and has experience supporting digital therapeutics, AI software, innovative devices, diagnostics, biomaterials for tissue repair, and aesthetic fillers. The company holds ISO 14155 certification for international standards in medical device clinical trials.

Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Beyond the preview

Go deeper on 프로메디스.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 프로메디스.

Explore the full profile